News & Articles

Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg

The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target

Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations

It is hoped the project will lead to improved quality of life for patients

Top talks presenting the latest technologies, research and applications are now available on demand

Electronic devices could be used to identify the presence of infection using body odor profiles

Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test

The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies

Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India

The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)

Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D

Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally

A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen.

Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%

The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples

New findings pave way to potentially improved assessment of measurable residual disease in AML patients

New service reduces project time from months to weeks for biopharma customers